Free Trial

Envoy Medical (COCH) Competitors

Envoy Medical logo
$1.15 -0.03 (-2.54%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$1.15 0.00 (-0.35%)
As of 08/22/2025 07:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

COCH vs. NSPR, HYPR, OBIO, ZJYL, FONR, NVNO, BDMD, APYX, VANI, and INO

Should you be buying Envoy Medical stock or one of its competitors? The main competitors of Envoy Medical include InspireMD (NSPR), Hyperfine (HYPR), Orchestra BioMed (OBIO), Jin Medical International (ZJYL), Fonar (FONR), enVVeno Medical (NVNO), Baird Medical Investment (BDMD), Apyx Medical (APYX), Vivani Medical (VANI), and Inovio Pharmaceuticals (INO). These companies are all part of the "medical equipment" industry.

Envoy Medical vs. Its Competitors

InspireMD (NYSE:NSPR) and Envoy Medical (NASDAQ:COCH) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, media sentiment, dividends, institutional ownership, earnings, analyst recommendations, profitability and valuation.

In the previous week, Envoy Medical had 1 more articles in the media than InspireMD. MarketBeat recorded 1 mentions for Envoy Medical and 0 mentions for InspireMD. InspireMD's average media sentiment score of 0.00 beat Envoy Medical's score of -0.36 indicating that InspireMD is being referred to more favorably in the media.

Company Overall Sentiment
InspireMD Neutral
Envoy Medical Neutral

44.8% of InspireMD shares are held by institutional investors. Comparatively, 8.6% of Envoy Medical shares are held by institutional investors. 34.1% of InspireMD shares are held by company insiders. Comparatively, 58.9% of Envoy Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

InspireMD has a net margin of -413.96% compared to Envoy Medical's net margin of -10,961.26%. Envoy Medical's return on equity of 0.00% beat InspireMD's return on equity.

Company Net Margins Return on Equity Return on Assets
InspireMD-413.96% -69.42% -57.68%
Envoy Medical -10,961.26%N/A -236.14%

InspireMD has higher revenue and earnings than Envoy Medical. InspireMD is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
InspireMD$7.07M14.05-$19.92M-$0.83-2.87
Envoy Medical$220K112.49-$20.80M-$1.43-0.80

InspireMD currently has a consensus price target of $4.50, suggesting a potential upside of 89.08%. Envoy Medical has a consensus price target of $9.25, suggesting a potential upside of 704.35%. Given Envoy Medical's higher probable upside, analysts clearly believe Envoy Medical is more favorable than InspireMD.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
InspireMD
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Envoy Medical
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

InspireMD has a beta of 0.6, meaning that its share price is 40% less volatile than the S&P 500. Comparatively, Envoy Medical has a beta of 2.21, meaning that its share price is 121% more volatile than the S&P 500.

Summary

InspireMD and Envoy Medical tied by winning 7 of the 14 factors compared between the two stocks.

Get Envoy Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for COCH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COCH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

COCH vs. The Competition

MetricEnvoy MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$24.75M$7.12B$5.83B$9.78B
Dividend YieldN/A1.28%4.40%4.05%
P/E Ratio-0.8027.4531.3026.05
Price / Sales112.4975.20454.60117.80
Price / CashN/A21.9338.0259.36
Price / Book-0.836.889.536.60
Net Income-$20.80M$176.42M$3.26B$265.65M
7 Day Performance-19.01%1.45%2.14%2.01%
1 Month Performance-28.13%-2.71%2.81%-0.33%
1 Year Performance-58.93%9.40%30.70%19.04%

Envoy Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
COCH
Envoy Medical
3.0444 of 5 stars
$1.15
-2.5%
$9.25
+704.3%
-58.3%$24.75M$220K-0.8034Gap Up
NSPR
InspireMD
3.5678 of 5 stars
$2.41
-3.2%
$4.50
+86.7%
-16.5%$100.55M$7.07M-3.2150
HYPR
Hyperfine
1.7062 of 5 stars
$1.27
-1.6%
$1.28
+1.0%
+22.2%$98.84M$12.89M-2.44190
OBIO
Orchestra BioMed
3.1441 of 5 stars
$2.55
-3.0%
$14.00
+449.0%
-58.7%$98.53M$2.64M-1.394Analyst Forecast
ZJYL
Jin Medical International
N/A$0.60
-0.9%
N/A-79.4%$94.59M$23.50M0.00245News Coverage
Positive News
FONR
Fonar
N/A$15.11
+0.1%
N/A-11.0%$93.68M$102.88M12.09480
NVNO
enVVeno Medical
0.6727 of 5 stars
$4.19
-16.0%
N/A-81.4%$80.65MN/A-3.4930Analyst Downgrade
High Trading Volume
BDMD
Baird Medical Investment
N/A$2.09
-1.9%
N/AN/A$74.68MN/A0.00N/A
APYX
Apyx Medical
1.253 of 5 stars
$1.97
-7.9%
N/A+60.8%$74.51M$48.10M-4.38270Gap Down
VANI
Vivani Medical
2.4065 of 5 stars
$1.21
-2.4%
$4.00
+230.6%
-8.1%$71.68MN/A-2.6920News Coverage
INO
Inovio Pharmaceuticals
4.1947 of 5 stars
$1.94
+2.1%
$8.80
+353.6%
-73.5%$71.14M$220K-0.74320

Related Companies and Tools


This page (NASDAQ:COCH) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners